RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen
Transfusion · 2024
DOI: 10.1111/trf.17691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von David Juhl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck/Kiel, Germany. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Blood Group Antigens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Serologic typing with monoclonal anti‐D is mandatory for RHD antigen determination before transfusion, but due to aberrant (weak or partial) variants of RHD, results may be ambiguous and molecular RHD‐typing is required. Before that, RHD‐negative (RHD –) red blood cells concentrates (RBCs) shall be transfused to avoid anti‐D formation, which probably leads to wastage of RHD ‐ RBCs. Study Design and Methods All patients with ambiguous results in serologic RHD‐typing and molecular RHD‐typing were assessed retrospectively. The proportions of patients at risk for anti‐D formation and the proportion of RHD ‐ RBCs transfused unnecessarily were evaluated for the following transfusion strategies: (1) RHD‐positive (RHD + )RBCs for all patients, (2) RHD + RBCs for patients with at least 2+ reaction with anti‐D, (3) RHD + RBCs for patients with C and/or E in their RHCE‐phenotype, (4) RHD + RBCs for patients with C and/or E and at least 2+ reaction, and (5) RHD ‐ RBCs for all patients.
Results
A total of 112 patients were included. Most had weak D type 1–3 and a minority had other, rare RHD variants. The risk of anti‐D formation was 4.5%, 2.9%, 1.8%, 1.0%, and 0% for strategies 1–5, respectively. The proportion of RHD ‐ RBCs transfused unnecessarily was 0%, 49.5%, 0.9%, 50.5%, and 95.5%.
Conclusion
Transfusing patients with a C and/or E in their RHCE‐phenotype with RHD + RBCs resulted in a very low risk of immunization while avoiding wastage of RHD ‐ RBCs. Therefore, this strategy should be used for some patients with ambiguous results in serologic RHD‐typing and pending results of molecular RHD‐typing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck/Kiel, Germany.
ORCID-Profile: David Juhl, Malte Ziemann
Zitieren
APA
Juhl, D., Luckner, K., Brockmann, C., Musiolik, I., Bunge-Philipowski, T., Görg, S., & Ziemann, M. (2024). RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen. Transfusion. https://doi.org/10.1111/trf.17691
Vancouver
Juhl D, Luckner K, Brockmann C, Musiolik I, Bunge-Philipowski T, Görg S, et al. RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen. Transfusion. 2024. doi:10.1111/trf.17691
BibTeX
@article{Juhl2024,
author = {Juhl, David and Luckner, Kathrin and Brockmann, Christian and Musiolik, Ingrid and Bunge-Philipowski, Tina and Görg, Siegfried and Ziemann, Malte},
title = {RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17691}
}
EUVIMED